Our medical nutrition range VALENS® unveiled its latest breakthrough – Vutycid™, the first-ever calcium butyrate designed to target irritable bowel syndrome and inflammatory bowel disease – at the prestigious Malaysian Dietitians’ Association (MDA) symposium this year (2024).
The launch gained momentum with an insightful lunch talk by Dr Chee Liang Choong, renowned Paediatric Gastroenterologist from Island Hospital Penang. Dr. Choong’s presentation, titled “Calcium Butyrate: From Gut to Peripheral,” explored the power of Butyrate, and was met with enthusiastic interest and response from fellow dietitians and delegates present.
Vutycid™, alongside Onthera+ ™, VALENS’ latest oral immunonutrition supplement, signifies a new chapter for the VALENS® medical nutrition range. These advancements aim to further empower Dietitians and healthcare professionals to achieve superior patient care and elevate patients’ quality of life.
Learn more about Vutycid™ and Onthera+™ and how medical nutrition can revolutionize your approach to patient care here: www.valensnutrition.com
VALENS® is a Pharm-D Health Science brand and trademark.
Pharm-D Health Science (PDHS) is a diversified healthcare group at the forefront of scientific innovation. We specialize in niche pharmaceuticals, medical nutrition, supplements, and medical devices, with advanced manufacturing and research capabilities in probiotics and bio-processing.
